Company Overview - SeaStar Medical is a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure[5] - The company's SCD therapy targets the upstream source of effector cells and neutralizes effector cells that release cytokines[28] - The SCD conveniently connects with existing continuous kidney renal therapy that is widely available in U S ICUs today[36] Clinical Data and Approvals - QUELIMMUNE is approved by the FDA as a Humanitarian Use Device (HUD) to treat pediatric patients with acute kidney injury and sepsis or septic condition weighing 10 kilograms and requiring kidney replacement therapy[22] - QUELIMMUNE clinical data in pediatric acute kidney injury shows a 77% survival rate at Day 60 compared to 50% with standard of care[42] - In adult AKI studies, 87.5% of pediatric patients had normal kidney function at Day 60[45] Market Opportunity - The total US annual market opportunity for the Adult AKI market is ~$4.5 billion, which is 50 times the size of the Pediatric AKI market (~$100 million)[24] - The adult acute kidney injury population is 50x larger than the pediatric population[18] Financials - As of May 14, 2025, the company has a market capitalization of $13.5 million[69]

Financial Performance & Growth - OneWater Marine Inc achieved a 47% Compound Annual Growth Rate (CAGR) in Adjusted EBITDA and a 31% CAGR in Revenue from FY17 to FY23[11, 42] - In Q3 2024, total revenue was $542441 thousand, a decrease of 87% year-over-year compared to $594339 thousand in Q3 2023[62] - Adjusted EBITDA for Q3 2024 was $39206 thousand, a decrease of 366% compared to $61883 thousand in Q3 2023, with a margin of 72%[62] - Net income for Q3 2024 was $16714 thousand, a decrease of 498% compared to $33290 thousand in Q3 2023[62] Acquisition Strategy & Returns - The company aims to acquire dealerships at less than 40x EV/EBITDA and double their EBITDA within 24 months[23] - Acquisitions from FY16 to FY22, with a combined purchase price of $386 million and preacquisition EBITDA of $78 million, generated $135 million in FY23 EBITDA, resulting in a 35% Return on Invested Capital (ROIC) and a 29x FY23 EV/EBITDA multiple[23, 24] - Acquisitions from FY16 to FY18, with a combined purchase price of $72 million and preacquisition EBITDA of $16 million, generated $58 million in FY23 EBITDA, resulting in an 80% ROIC and a 13x FY23 EV/EBITDA multiple[25, 26] Revenue Streams & Inventory - New boat sales contribute 50% to revenue and 64% to gross profit, while pre-owned boat sales contribute 10% to revenue and 14% to gross profit[21] - Finance & Insurance contribute 3% to revenue and 17% to gross profit, while service, parts, and other contribute 16% to revenue and 26% to gross profit[21] Market Position & Footprint - The company has retail locations across 16 states, with 12 of those states being in the top 20 boating states[18]

Ondas Autonomous Systems (OAS) - OAS is positioned to achieve at least $20 million in expected revenues for 2025, entering the year with a $10 million backlog[22] - The company anticipates generating $25 million in revenue in 2025[23] - The combined Total Addressable Market (TAM) for Iron Drone Raider and Optimus System is estimated at $53 billion and $22 billion, respectively[27] - Initial Obtainable Market (SOM) through 2026 for Iron Drone is $70 million and for Optimus is $50 million[31] - Secured ~$144 million in purchase orders in Q3 2024[32] Ondas Networks - The total addressable market for private wireless Rail networks in North America is in excess of $13 billion[78] - Railroads could potentially drive ~$5 billion of additional revenue with a ~5% productivity increase[75] Financial Performance (Q1 2025) - Net revenues increased to $4248182, a 580% increase compared to $625009 in the same period last year[103, 104] - The company has a cash balance of $254 million, compared to $146 million a year ago[105, 106] - Holdings Convertible Debt reduced by $192 million to $254 million at the end of Q1 2025[108]

2024 Accomplishments - Natural gas prices averaged $1.98 per Mcf, a 30-year low excluding 2020[6] - The company increased its hedging program, improving realized gas price by 20% in 2024 and targeting 50% of expected production for 2025 and 2026[6] - The company added $100.5 million through an equity private placement and enhanced liquidity with a $400 million senior notes offering[6] - The company more than doubled its Western Haynesville acreage by adding 265,000 net acres at a cost of $401 per acre[6] - The company's drilling program replaced 170% of 2024 production and drove 6% reserve growth with 899 Bcfe of drilling related proved reserve additions, achieving an overall finding cost of $1.00 per Mcfe[6] Drilling and Efficiency - The company completed its first horseshoe well, the Sebastian 11 5, with a 9,382-foot lateral and a 31 MMcf per day initial production rate[11] - D&C costs for two 9,200-foot horseshoe laterals is $32 million or $1,740 per lateral foot, resulting in D&C Savings of $530 per lateral foot or 23%[11] - 13 operated Legacy Haynesville wells were turned to sales in Q1 2025 with an average lateral length of 12,367 ft and an average IP rate of 24 Mmcf/d[25] - One operated Western Haynesville well was turned to sales in Q1 2025 with a lateral length of 10,306 ft and an IP rate of 41 Mmcf/d[29] Financials and Outlook - The company spent $902 million in 2024 to add 899 Bcfe of Proved Reserves achieving all in finding costs of $1.00 per Mcfe[58] - As of March 31, 2025, the company had $33 million in cash and cash equivalents and $3.099 billion in total debt[62] - The company has strong financial liquidity of $1.0 billion[73]

Company Overview - Gladstone Land owns 150 farms with approximately 103,000 acres in 15 states and over 55,000 acre-feet of water assets in California, with 95.9% occupancy[10] - The company focuses on farmland growing fresh produce and permanent crops[11, 16] - Gladstone Land is managed by an SEC-registered investment advisor with over $4 billion of assets under management[12] Market Opportunity and Investment Focus - The company primarily focuses on acquiring high-value farmland that generates above-average revenues and profits[35] - The company targets transaction sizes between $2 million to $50 million+[43] - From 1980 through 2024, the Fresh Fruits & Vegetables segment of the Food & Beverages category increased by 385%[45] - U.S farmland value is approximately $3.4 trillion, with approximately 63% of U.S farm operators are over 55 years of age[65] Financial Performance - Since its IPO in 2013, the company has made 147 consecutive monthly cash distributions to common shareholders, totaling $7.32 per share[76] - Over the past 41 quarters, the company has increased the common distribution rate 35 times for a total increase of 55.7%[76] - The company's weighted-average remaining lease term is 6.7 years[83] - The company's weighted-average debt maturity is 7.4 years with a weighted-average effective interest rate of 3.41%, fixed for 3.5 years[84]

Financial Performance & Growth - Black Hills Corp achieved a solid financial position with a long-term EPS growth target of 4% to 6% off the 2023 base of $3.75 per share[9] - The company targets a 55%-65% dividend payout ratio and has increased its annual dividend for 55 consecutive years[9] - The company is delivering on 2025 earnings guidance, which represents ~5% year-over-year growth, achieving 4%-6% CAGR off 2023 base[11] Capital Investment & Infrastructure - Black Hills Corp has a five-year capital forecast of $4.7 billion for 2025-2029, a 10% increase from the prior five-year plan[11] - The company's capital investment plan includes $2.4 billion for electric utilities and $2.1 billion for gas utilities[93] - The company is undertaking the Ready Wyoming Electric Transmission Initiative, a 260-mile expansion project costing $350 million[33] Data Center & Customer Growth - Black Hills Corp announced 1 GW of data center demand from existing customers, with ~500 MW in the current plan requiring minimal capital[11] - The company expects data center EPS contribution to more than double to 10%+ by 2028[17] - The company's customer count growth is more than double the population growth, with a customer count CAGR of 1.1% from 2019-2024[20, 23] Regulatory & Sustainability - The company is actively executing three to four rate reviews per year, including a filed rate review for Kansas Gas requesting recovery of $17.2 million[11, 18] - Black Hills Corp is committed to reducing GHG emissions intensity 40% by 2030 and 70% by 2040 for electric utilities (2005 baseline)[110] - The company targets Net Zero GHG emissions by 2035 for the natural gas distribution system[110]

(#) Huntington 2025 Annual Shareholders' Meeting Welcome. April 16, 2025 The Huntington National Bank is Member FDIC. I = Huntington® and [ Huntington. Welcome.® are federally registered service marks of Huntington Bancshares Incorporated. ©2025 Huntington Bancshares Incorporated. Deeply Engaged Board of Directors ll HuntinQton Board composition of as of April 16, 2025 2025 Annual Shareholders' Meeting 2 Stephen Steinour Chairman, President, and CEO Huntington Bancshares Incorporated President and CEO The H ...

JuLY 2025 : NXPL Forward-Looking Statement This presentation contains forward-looking statements and projections. The Company makes no express or implied representation or warranty as to the completeness of this information or, in the case of projections, as to their attainability or the accuracy and completeness of the assumptions from which they are derived, and it is expected that each prospective investor will pursue his, her, or its own independent investigation. It must be recognized that estimates of ...

Dorzagliatin Overview - Dorzagliatin is a first-in-class drug with global rights, targeting the underlying cause of Type 2 Diabetes (T2D) by addressing impaired glucose homeostasis[13] - As of December 31, 2019, Hua Medicine had RMB 1.1 billion in cash[13] - The global T2D population is 453 million, with 120 million in China alone, representing a massive market opportunity[13] Clinical Trial Results - In a Phase III monotherapy trial, dorzagliatin achieved the primary endpoint, demonstrating a significant and sustainable reduction in HbA1c safely[13] - In the HMM0301 Phase III trial, the dorzagliatin-treated group showed a 1.07% HbA1c reduction from a baseline of 8.35%, compared to a 0.5% reduction from a baseline of 8.37% in the placebo group (p < 0.0001)[62] - 45.4% of patients treated with dorzagliatin achieved a target HbA1c level of 7.0% or less at 24 weeks, compared to 21.5% of patients treated with placebo (p < 0.0001)[62] - Patients treated with dorzagliatin achieved a homeostasis control rate of 45.0% compared with 21.5% in the placebo group (p < 0.0001)[62] Combination Therapy - A Phase I trial (HMM0111) showed that dorzagliatin combined with sitagliptin (DPP-4 inhibitor) resulted in a 33% reduction (p<0.01) in postprandial glucose level AUEC (0-4hr)[74] - A Phase I trial (HMM0112) showed that dorzagliatin combined with empagliflozin (SGLT-2 inhibitor) resulted in a 38% reduction (p<0.0001) in postprandial glucose level AUEC (0-4hr)[79] China Market - China has the largest diabetes population globally, with approximately 125 million T2D patients[232] - The diagnosis rate in China was 50.4% in 2018 and is expected to rise to 82.2% in 2028[235] - The China anti-diabetics market is projected to grow from RMB 57.3 billion in 2018 to RMB 135.6 billion in 2025, with an expected CAGR of 11.7% from 2018 to 2028[246]

Company Performance & Strategy - Newell's net sales were $7.6 billion [9] - Approximately 90% of sales are attributed to 25 brands [9] - International sales account for 38% of total sales [9] - In 2024, the company implemented a new corporate strategy based on a capability assessment conducted in 2023 [17, 39, 102, 146] - The company is focused on its top 10 brands [30] Financial Improvements & Outlook - TTM normalized EBITDA was $884 million as of Q1 2025 [9] - TTM Normalized Gross Margin percentage is 31.9%, reflecting a +610 bps increase [113] - Operating cash flow improved by over $750 million from FY22 to FY24 [138] - The company reduced net debt by approximately $175 million in 2024 [138] - The leverage ratio decreased from 5.8x in FY23 to 4.9x in FY24 [140] Supply Chain & Cost Optimization - China to US sourcing has been reduced from 35% to less than 10% by the end of 2025 [91] - The company has reduced its supply base by approximately 45% since 2020 [122] - Transportation costs decreased by 40 bps in 2024 [114, 126] - Headcount has been reduced by 14% since 2022 [132]